Literature DB >> 25010140

The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.

Laura Rio-Marques1, Axel Hartke, Alain Bizzini.   

Abstract

OBJECTIVES: The inoculum effect (IE) is an increase in the minimum inhibitory concentration (MIC) at high bacterial densities. The effect of three inoculum sizes on the selection of resistance to vancomycin, daptomycin, and linezolid was investigated in methicillin-resistant Staphylococcus aureus (MRSA).
METHODS: Low (10(4) CFU/ml), medium (10(6) CFU/ml), and high (10(8) CFU/ml) inocula of MRSA were exposed to twofold increasing concentrations of either drug during 15 days of cycling. MICs for low (MICL), medium (MICM), and high (MICH) inocula were determined daily. Conventional MICs were measured at days 1, 5, 10, and 15. Experiments were performed in triplicate.
RESULTS: At the beginning of the experiment a small IE was observed for vancomycin (MICL=1 μg/ml, MICM=1-2 μg/ml, and MICH=2 μg/ml) and a significant IE for daptomycin (MICL=0.25 μg/ml, MICM=0.25-0.5 μg/ml, and MICH=2 μg/ml). Linezolid exhibited no IE at low and medium inocula (MICL=1 μg/ml and MICM=1-2 μg/ml), but with the high inoculum, concentrations up to 2,048 μg/ml did not fully inhibit visual growth. During cycling, increase of MIC was observed for all antibiotics. At day 15, MICL, MICM, and MICH of vancomycin were 2-4, 4-8, and 4-16 μg/ml and of daptomycin were 0.5-2, 8-128, and 64-256 μg/ml, respectively. MICL and MICM of linezolid were 1 and 2-4 μg/ml, respectively. Conventional MICs showed vancomycin and daptomycin selection of resistance since day 5 depending on the inocula. No selection of linezolid resistance was observed.
CONCLUSIONS: Our results showed the importance of the inoculum size in the development of resistance. Measures aimed at lowering the inoculum at the site of infection should be used whenever possible in parallel to antimicrobial therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25010140     DOI: 10.1089/mdr.2014.0059

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  5 in total

1.  Bactericidal activity of curcumin I is associated with damaging of bacterial membrane.

Authors:  Poonam Tyagi; Madhuri Singh; Himani Kumari; Anita Kumari; Kasturi Mukhopadhyay
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

Review 2.  Antimicrobial Activity and Resistance: Influencing Factors.

Authors:  Jun Li; Shuyu Xie; Saeed Ahmed; Funan Wang; Yufeng Gu; Chaonan Zhang; Ximan Chai; Yalan Wu; Jinxia Cai; Guyue Cheng
Journal:  Front Pharmacol       Date:  2017-06-13       Impact factor: 5.810

3.  Bistable Bacterial Growth Dynamics in the Presence of Antimicrobial Agents.

Authors:  Nelly Frenkel; Ron Saar Dover; Eve Titon; Yechiel Shai; Vered Rom-Kedar
Journal:  Antibiotics (Basel)       Date:  2021-01-18

4.  PKPD Modeling of the Inoculum Effect of Acinetobacter baumannii on Polymyxin B in vivo.

Authors:  Alexia Chauzy; Grace Akrong; Vincent Aranzana-Climent; Jérémy Moreau; Laure Prouvensier; Hélène Mirfendereski; Julien M Buyck; William Couet; Sandrine Marchand
Journal:  Front Pharmacol       Date:  2022-03-16       Impact factor: 5.810

5.  High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus.

Authors:  Rafael San-Juan; Esther Viedma; Fernando Chaves; Antonio Lalueza; Jesús Fortún; Elena Loza; Miquel Pujol; Carmen Ardanuy; Isabel Morales; Marina de Cueto; Elena Resino-Foz; Alejandra Morales-Cartagena; Alicia Rico; María P Romero; María Ángeles Orellana; Francisco López-Medrano; Mario Fernández-Ruiz; José María Aguado
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.